Gregg H. Alton's Insider Trades & SAST Disclosures
Gregg H. Alton's most recent trade in Renovaro Biosciences Inc was a trade of 48,137 Option to purchase shares of common stock done . Disclosure was reported to the exchange on June 25, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Gregg H. Alton.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Renovaro Biosciences Inc | Gregg H. Alton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 48,137 | 48,137 | - | - | Option to purchase shares of common stock | |
| Novavax, Inc. | Gregg H. Alton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 15,630 | 15,630 | - | - | Stock Option (Right to Buy) | |
| Novavax, Inc. | Gregg H. Alton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 10,420 | 10,420 | - | - | Restricted Stock Units | |
| Novavax, Inc. | Gregg H. Alton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2024 | 6,670 | 10,470 (0%) | 0% | 0 | Common Stock | |
| Novavax, Inc. | Gregg H. Alton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2024 | 6,670 | 0 | - | - | Restricted Stock Units | |
| Corcept Therapeutics Inc | Gregg H. Alton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 30,000 | 30,000 | - | - | Stock option (right to buy) | |
| Novavax, Inc. | Gregg H. Alton | Director | Grant, award, or other acquisition of securities at price $ 4.90 per share. | 31 Mar 2024 | 3,420 | 7,220 (0%) | 0% | 4.9 | 16,758 | Common Stock |
| Novavax, Inc. | Gregg H. Alton | Director | Grant, award, or other acquisition of securities at price $ 8.61 per share. | 31 Mar 2024 | 1,982 | 18,385 (0%) | 0% | 8.6 | 17,065 | Common Stock |
| Novavax, Inc. | Gregg H. Alton | Director | Grant, award, or other acquisition of securities at price $ 12.77 per share. | 31 Mar 2024 | 1,311 | 16,403 (0%) | 0% | 12.8 | 16,741 | Common Stock |
| Novavax, Inc. | Gregg H. Alton | Director | Grant, award, or other acquisition of securities at price $ 13.93 per share. | 31 Mar 2024 | 1,202 | 15,092 (0%) | 0% | 13.9 | 16,744 | Common Stock |
| Renovaro Biosciences Inc | H. Alton Gregg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Dec 2023 | 23,810 | 23,810 | - | - | Option to purchase shares of common stock | |
| Novavax, Inc. | Gregg H. Alton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2023 | 7,710 | 7,710 | - | - | Stock Option (Right to Buy) | |
| Novavax, Inc. | Gregg H. Alton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2023 | 6,670 | 6,670 | - | - | Restricted Stock Units | |
| Novavax, Inc. | Gregg H. Alton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2023 | 3,100 | 3,800 (0%) | 0% | - | Common Stock | |
| Novavax, Inc. | Gregg H. Alton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2023 | 3,100 | 0 | - | - | Restricted Stock Units | |
| Corcept Therapeutics Inc | Gregg H. Alton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2023 | 30,000 | 30,000 | - | - | Stock option (right to buy) | |
| Renovaro Biosciences Inc | Gregg H. Alton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Dec 2022 | 57,252 | 57,252 | - | - | Option to purchase shares of common stock | |
| Novavax, Inc. | Gregg H. Alton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jun 2022 | 700 | 0 | - | - | Restricted Stock Units | |
| Novavax, Inc. | Gregg H. Alton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jun 2022 | 700 | 700 (0%) | 0% | - | Common Stock | |
| Novavax, Inc. | Gregg H. Alton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 4,600 | 4,600 | - | - | Stock Option (Right to Buy) | |
| Novavax, Inc. | Gregg H. Alton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 3,100 | 3,100 | - | - | Restricted Stock Units | |
| Corcept Therapeutics Inc | Gregg H. Alton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 20,000 | 20,000 | - | - | Stock option (right to buy) | |
| Renovaro Biosciences Inc | Gregg H. Alton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Dec 2021 | 9,458 | 9,458 | - | - | Option to purchase shares of common stock | |
| Novavax, Inc. | Gregg H. Alton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 1,300 | 1,300 | - | - | Stock Option (Right to Buy) | |
| Novavax, Inc. | Gregg H. Alton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 700 | 700 | - | - | Restricted Stock Units | |
| Corcept Therapeutics Inc | Gregg H. Alton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Novavax, Inc. | Gregg H. Alton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2020 | 7,700 | 7,700 | - | - | Stock Option (Right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges